A Study to Evaluate the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor

NCT05366751 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

97

Enrollment

INDUSTRY

Sponsor class

Stopped Internal company decision

Conditions

Essential Tremor

Interventions

DRUG: SAGE-324

Sponsor

Sage Therapeutics